Point of Care (POC) Infection Control Market
By Product Type;
Germicidal Wipes, Effervescent Disinfectant Sanitizer Tablets, Hand Hygiene, and OthersBy Infection Type;
Nosocomial Infections and Healthcare-Associated Infections (HAIs)By Application;
Hospitals, Clinics, Homecare Settings, and Ambulatory Surgery CentersBy End-User;
Healthcare Providers, Diagnostic Laboratories, Research Institutes, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Point Of Care Infection Control Market Overview
Point Of Care Infection Control Market (USD Million)
Point Of Care Infection Control Market was valued at USD 1615.04 million in the year 2024. The size of this market is expected to increase to USD 2593.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.
Point of Care (POC) Infection Control Market
*Market size in USD million
CAGR 7.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 7.0 % |
Market Size (2024) | USD 1615.04 Million |
Market Size (2031) | USD 2593.40 Million |
Market Concentration | Medium |
Report Pages | 312 |
Major Players
- 3M
- Premier
- Stanley
- SW Safety Solutions
- Global Life Technologies
- Magnolia Medical Technologies
- Siemens
- Thermo Fisher Scientific
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Point of Care (POC) Infection Control Market
Fragmented - Highly competitive market without dominant players
The Point Of Care Infection Control Market is experiencing impressive growth, with over 64% of healthcare services adopting on-the-spot diagnostic tools to manage infections efficiently. The surge in demand for faster and accurate testing is accelerating the development of innovative solutions tailored for immediate use. These advancements are opening up new opportunities for smarter and safer care delivery, reinforcing the importance of infection control in point-of-care environments.
Innovation Transforming Infection Control Practices
Around 51% of the current market investments are channelled into automated and advanced disinfection systems that support point-of-care delivery. This wave of innovation is redefining traditional approaches by introducing compact, high-efficiency tools that ensure both speed and sanitation. The market is responding to the rising need for precision, adaptability, and real-time infection management.
Next-Gen Technologies and Future Trends
Nearly 49% of development initiatives are centered on AI-powered diagnostics and smart infection detection systems. These cutting-edge technologies improve both reliability and response time, minimizing infection risks at the point of contact. With these tools becoming more accessible, the market’s future outlook points to further technological integration that enhances operational efficiency and patient protection.
Market Expansion through Opportunity-Driven Strategy
With over 58% of healthcare providers now emphasizing point-of-care infection protocols, the market continues to expand through strategic investments and scalable innovations. The growing reliance on portable disinfection and rapid testing creates ample room for growth, pushing companies to develop targeted solutions that address shifting healthcare priorities. These developments signal a strong path ahead for market expansion and long-term value creation.
Point Of Care Infection Control Market Recent Developments
-
In October 2020, Cepheid launched the Xpert Xpress SARS-CoV-2/Flu/RSV Test, a rapid point-of-care test that can detect SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in under 30 minutes. This multi-pathogen testing capability enhances infection control efforts by allowing healthcare providers to quickly identify and manage viral respiratory infections, improving patient outcomes and reducing transmission risks.
-
In December 2020, Quidel received FDA emergency use authorization for the Sofia 2 SARS Antigen Fluorescent Immunoassay. This point-of-care test provides rapid results for SARS-CoV-2 detection, helping healthcare providers implement timely infection control measures, especially in emergency settings.
Point of Care Infection Control Market Segment Analysis
In this report, the Point of Care Infection Control Market has been segmented by Product Type, Infection Type, Application, End-User, and Geography.
Point of Care Infection Control Market, Segmentation by Product Type
The Point of Care Infection Control Market has been segmented by Product Type into Germicidal Wipes, Effervescent Disinfectant Sanitizer Tablets, Hand Hygiene, and Others.
Germicidal Wipes
Germicidal wipes are essential in point-of-care settings for surface disinfection and infection containment. These pre-moistened products are widely used in hospitals and clinics for their convenience and effectiveness. The demand is driven by the rise in HAIs and the need for quick sanitation between patient interactions. Enhanced formulations targeting a broad spectrum of pathogens are improving efficacy and safety compliance.
Effervescent Disinfectant Sanitizer Tablets
Effervescent disinfectant tablets offer long shelf life and on-demand preparation, making them suitable for resource-limited or mobile medical environments. Their adoption is increasing in emergency response and homecare settings. Tablets also minimize storage space and reduce packaging waste. The ability to reconstitute powerful disinfectants in small volumes supports cost-efficiency and sustainability goals.
Hand Hygiene
Hand hygiene products, including alcohol-based sanitizers and antimicrobial soaps, are pivotal in breaking transmission chains at the point of care. As infection control becomes a core priority post-COVID, hospitals and outpatient clinics are expanding hygiene stations. Regulatory bodies continue to emphasize compliance, while innovations in skin-friendly formulas are increasing usage frequency.
Others
This category includes sprays, UV sterilizers, and wipes for medical equipment disinfection. The increasing focus on multi-modal infection control strategies has led to demand for auxiliary products. Compact sterilization devices are gaining traction in ambulatory settings. Market players are introducing hybrid disinfection kits to cater to evolving clinical needs across various care environments.
Point of Care Infection Control Market, Segmentation by Infection Type
The Point of Care (POC) Infection Control Market has been segmented by Infection Type into Nosocomial Infections and Healthcare-Associated Infections (HAIs).
Nosocomial Infections
Nosocomial infections, acquired within healthcare facilities, remain a significant burden worldwide. Point-of-care solutions are vital for preventing transmission during routine patient interactions. Increasing awareness of hospital-acquired infections and regulatory mandates is fueling investment in targeted disinfection protocols. Integration of real-time monitoring systems further strengthens infection surveillance.
Healthcare-Associated Infections (HAIs)
HAIs encompass a broad range of infections like CLABSIs, CAUTIs, and VAPs. Infection control tools at the bedside, including touchless hygiene dispensers and disposable barriers, are being widely adopted. Healthcare systems are expanding staff training and implementing automated hygiene audits. Rising litigation costs and quality scoring initiatives are incentivizing infection control spending.
Point of CareInfection Control Market, Segmentation by Application
The Point of Care (POC) Infection Control Market has been segmented by Application into Hospitals, Clinics, Homecare Settings, and Ambulatory Surgery Centers.
Hospitals
Hospitals remain the largest application segment due to high patient turnover and invasive procedures. Infection control measures are deeply integrated into hospital workflows, from ICUs to emergency rooms. Investments in training, audits, and compliance with global standards like WHO and CDC guidelines are driving usage. The expansion of tertiary care facilities further boosts the segment.
Clinics
Clinics are increasingly investing in POC disinfection systems to safeguard staff and patients. High demand for cost-effective, portable solutions like wipes and tablet-based disinfectants is observed. Smaller practices focus on maintaining hygiene between rapid patient visits. Growth in outpatient consultations is making infection prevention protocols a routine necessity in clinics.
Homecare Settings
In homecare, infection control relies on simple, user-friendly products such as sprays, sanitizer wipes, and disposable gloves. Rising geriatric populations and post-acute care at home have expanded this segment. Educating caregivers and ensuring proper supply chains for hygiene products are key drivers. Manufacturers are developing solutions tailored to non-clinical users and self-care scenarios.
Ambulatory Surgery Centers
ASCs require compact, effective infection control tools that fit into fast-paced surgical workflows. Pre- and post-operative areas are equipped with germicidal stations, and patient-contact surfaces are frequently disinfected. Regulatory audits and accreditation standards are pushing centers to adopt automated dispensers and monitoring technologies. Demand is rising with the increase in same-day surgeries worldwide.
Point of Care Infection Control Market, Segmentation by End-User
The Point of Care Infection Control Market has been segmented by End-User into Healthcare Providers, Diagnostic Laboratories, Research Institutes, and Others.
Healthcare Providers
Healthcare providers including nurses, physicians, and support staff are primary users of POC infection control products. These end users require readily available and easy-to-use solutions at the bedside. Adherence to hand hygiene and environmental cleaning protocols is critical. Ongoing staff training and increasing accountability measures make this segment pivotal to infection control success.
Diagnostic Laboratories
Laboratories focus on contamination control to prevent false positives and protect staff. Point-of-care cleaning of surfaces, pipettes, and sample containers is essential. With increased handling of infectious samples, demand for fast-acting disinfectants and glove compliance solutions is growing. The expansion of decentralized testing further accelerates adoption in field labs and mobile testing units.
Research Institutes
Research environments emphasize biosafety protocols during high-risk experimentation. The need for sterile conditions and surface decontamination supports the use of advanced germicidal agents. Institutes also require compliance with international guidelines for lab safety. Rising biotech research and infectious disease modeling increase infection control product demand across these settings.
Others
This category includes caregivers, paramedics, and community health workers who operate in non-traditional or mobile care settings. Point-of-care infection prevention tools must be compact, portable, and rugged. With increased outreach efforts and home-based care, demand is growing for hygiene kits tailored for public health and emergency response use cases.
Point of Care Infection Control Market, Segmentation by Geography
In this report, the Point of Care Infection Control Market has been segmented by Geography into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
Point of Care Infection Control Market Share (%), by Geographical Region
North America
North America leads the market with a share of 41.7%, supported by stringent infection control regulations and high healthcare expenditure. The U.S. dominates the region with strong hospital accreditation frameworks and hygiene awareness campaigns. Investment in smart dispensers and touch-free systems continues to grow across all care levels. Rapid innovation and product launches further reinforce the region's leadership.
Europe
Europe accounts for 27.8% of the market, driven by national health policies and centralized procurement of disinfectant supplies. Countries like Germany and France prioritize antimicrobial resistance containment and point-of-use hygiene standards. Adoption of eco-friendly disinfection solutions is gaining momentum. EU-wide initiatives continue to support infection control improvements in both acute and long-term care.
Asia Pacific
Asia Pacific holds 18.6% market share and is rapidly growing due to rising hospital construction and healthcare modernization. Countries like China, India, and South Korea are adopting localized infection control protocols. Demand is particularly strong in urban hospitals and large ambulatory centers. Government and NGO-supported awareness drives are helping expand market presence in semi-urban areas.
Middle East & Africa
This region represents 6.2% of the market and is witnessing improvements in point-of-care hygiene practices. Investment in infection control training and surveillance is boosting adoption. Gulf countries lead in hospital-based disinfection systems, while African nations benefit from donor-supported hygiene kits. Expansion of community health worker programs is also creating demand.
Latin America
Latin America holds 5.7% of the market, with countries like Brazil and Mexico showing strong growth in hospital sanitation and outpatient infection prevention. Regulatory updates and pandemic-driven demand accelerated investments in disinfection systems. Portable sanitizers and disposable wipes are widely used in homecare and clinics, fueling product penetration across diverse healthcare settings.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Point Of Care Infection Control Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Rising Incidence of Infectious Diseases
- Growing Need for Rapid Diagnostics
-
Technological Advancements -Technological advancements play a pivotal role in driving the growth of the global point of care infection control market. The continuous innovation in medical technologies and infection control solutions has significantly enhanced the effectiveness, convenience, and efficiency of infection prevention measures across healthcare settings. The development of advanced hand hygiene products, such as alcohol-based hand sanitizers with improved formulations, has made it easier for healthcare professionals to maintain proper hygiene in high-pressure environments. In addition, the introduction of more efficient and user-friendly germicidal wipes, disinfectants, and effervescent disinfectant tablets has contributed to improved surface decontamination and infection prevention in hospitals, clinics, and other healthcare facilities.
Technological advancements in digital health have also led to the introduction of smart infection control solutions, such as electronic hand hygiene monitoring systems, which track and report compliance in real-time, helping healthcare institutions ensure adherence to hygiene protocols. Moreover, innovations in sterilization equipment and automated disinfection devices, such as UV-C light disinfection units and robotic cleaning systems, are revolutionizing the way hospitals and clinics maintain sterile environments. These devices reduce human error and enhance the efficiency of infection control procedures.
The integration of technology in infection control extends to homecare settings as well, where devices such as smart disinfectant dispensers and wearable hygiene sensors are gaining popularity. These innovations not only improve the ease of use but also enhance the overall effectiveness of infection prevention measures.
As healthcare providers increasingly adopt these advanced technologies to combat infections, the point of care infection control market is expected to grow significantly. The ongoing technological improvements contribute to the development of more efficient, cost-effective, and environmentally friendly solutions, thus fueling the demand for infection control products and services across various healthcare settings.
Restraints:
- High Initial Cost of Point-of-Care Devices
- Regulatory Challenges
-
Limited Awareness in Emerging Markets -Limited awareness in emerging markets presents a significant restraint for the global point of care infection control market. In many developing countries, there is still a lack of understanding about the importance of infection control and the potential risks associated with healthcare-associated infections (HAIs). This limited awareness can result in suboptimal implementation of infection prevention measures, such as proper hand hygiene, surface disinfection, and the use of protective equipment in healthcare settings. Additionally, there is often inadequate training among healthcare workers regarding infection control protocols, which can further contribute to the spread of infectious diseases in hospitals, clinics, and other healthcare facilities.
In some regions, particularly in rural or underserved areas, the lack of access to information and education about infection prevention can hinder the widespread adoption of point of care infection control products. The cultural, economic, and infrastructural challenges in these regions further complicate the issue, as many healthcare facilities may not prioritize infection control due to limited resources. This can lead to ineffective infection control practices, ultimately affecting patient safety and increasing the risk of infections.
The limited availability of high-quality infection control products in emerging markets, combined with the lack of awareness about their benefits, can slow down market growth. The affordability of infection control solutions is another key challenge, as many point of care infection control products may be considered expensive, especially in low-income regions where budget constraints are common.
Despite these challenges, efforts to increase awareness, educate healthcare workers, and improve infection control practices are gradually growing in emerging markets. However, the overall pace of adoption remains slow, making limited awareness a critical restraint to the growth of the point of care infection control market in these regions.
Opportunities:
- Expansion into Emerging Markets
- Integration with Telehealth Platforms
-
Development of Advanced POC Technologies -The development of advanced point-of-care (POC) technologies presents a significant opportunity for the global point of care infection control market. As healthcare systems increasingly demand quicker, more accurate, and efficient solutions to control infections, advancements in POC technologies offer the potential to revolutionize infection prevention and management. These technologies enable healthcare providers to perform rapid diagnostics and monitoring at the site of patient care, leading to quicker identification of infections and more timely interventions. For instance, the integration of molecular diagnostics, such as PCR-based tests, into point-of-care settings can allow for faster detection of pathogens, facilitating the immediate implementation of infection control measures.
The advancement of digital health solutions, including connected devices and smart sensors, presents new avenues for infection control. Wearable sensors, for example, can monitor hygiene compliance in real-time, ensuring that healthcare workers and patients follow proper infection control protocols. Additionally, the rise of artificial intelligence (AI) and machine learning (ML) in POC technologies can help predict infection outbreaks and monitor infection control measures by analyzing large volumes of healthcare data. These technologies enhance the accuracy and efficiency of infection control, which is critical in preventing healthcare-associated infections (HAIs).
The development of user-friendly and cost-effective POC devices tailored for healthcare settings, especially in resource-limited areas, presents an opportunity to expand the reach of infection control solutions globally. With better diagnostics and real-time monitoring, healthcare providers can enhance infection control measures, reduce the burden on hospitals, and improve patient outcomes. As the demand for faster, more efficient infection control continues to rise, these advanced POC technologies are poised to play a critical role in shaping the future of infection prevention across various healthcare settings.
Competitive Landscape Analysis
Key players in Global Point Of Care Infection Control Market include,
- 3M
- Premier
- Stanley
- SW Safety Solutions
- Global Life Technologies
- Magnolia Medical Technologies
- Siemens
- Thermo Fisher Scientific
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Infection Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Point Of Care Infection Control Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising Incidence of Infectious Diseases
- Growing Need for Rapid Diagnostics
- Technological Advancements
- Restraints
- High Initial Cost of Point-of-Care Devices
- Regulatory Challenges
- Limited Awareness in Emerging Markets
- Opportunities
- Expansion into Emerging Markets
- Integration with Telehealth Platforms
- Development of Advanced POC Technologies
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Point Of Care Infection Control Market, By Product Type, 2021 - 2031 (USD Million)
- Germicidal Wipes
- Effervescent Disinfectant Sanitizer Tablets
- Hand Hygiene
- Others
- Point Of Care Infection Control Market, By Infection Type, 2021 - 2031 (USD Million)
- Nosocomial Infections
- Healthcare-Associated Infections (HAIs)
- Point Of Care Infection Control Market, By Application, 2021 - 2031 (USD Million)
- Hospitals
- Clinics
- Homecare Settings
- Ambulatory Surgery Centers
- Point Of Care Infection Control Market, By End User, 2021 - 2031 (USD Million)
- Healthcare Providers
- Diagnostic Laboratories
- Research Institutes
- Others
- Point Of Care Infection Control Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Point Of Care Infection Control Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- 3M
- Premier
- Stanley
- SW Safety Solutions
- Global Life Technologies
- Magnolia Medical Technologies
- Siemens
- Thermo Fisher Scientific
- Company Profiles
- Analyst Views
- Future Outlook of the Market